Skip to main content

Articles

Page 26 of 38

  1. Several studies have shown that the antimuscarinic treatment of overactive bladder is characterized by low long-term persistence rates. We have investigated the persistence of solifenacin in real life by means...

    Authors: Marloes J. Tijnagel, Jeroen R. Scheepe and Bertil F. M. Blok
    Citation: BMC Urology 2017 17:30
  2. We evaluated the cancer detection rate of prostate cancer using transperineal template-guided saturation biopsy aimed at sampling one core for each milliliter of prostate volume for patients requiring repeated...

    Authors: Yasushi Nakai, Nobumichi Tanaka, Satoshi Anai, Makito Miyake, Shunta Hori, Yoshihiro Tatsumi, Yosuke Morizawa, Tomomi Fujii, Noboru Konishi and Kiyohide Fujimoto
    Citation: BMC Urology 2017 17:28
  3. The current standard for Prostate Cancer (PCa) detection in biopsy-naïve men consists of 10–12 systematic biopsies under ultrasound guidance. This approach leads to underdiagnosis and undergrading of significa...

    Authors: A. W. Postema, M. J. V. Scheltema, C. K. Mannaerts, R. J. G. Van Sloun, T. Idzenga, M. Mischi, M. R. E. Engelbrecht, J. J. M. C. H. De la Rosette and H. Wijkstra
    Citation: BMC Urology 2017 17:27
  4. The aim of the present study is to investigate the clinical relevance of aortic calcification in urolithiasis patients.

    Authors: Toshikazu Tanaka, Shingo Hatakeyama, Hayato Yamamoto, Takuma Narita, Itsuto Hamano, Teppei Matsumoto, Osamu Soma, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ippei Takahashi, Shigeyuki Nakaji, Yuriko Terayama, Tomihisa Funyu…
    Citation: BMC Urology 2017 17:25
  5. B7-H3, a member of the B7 family of the Ig superfamily of proteins, has been detected in the epididymis, which is a storage organ related to sperm maturation. However, the characteristics of its expression in ...

    Authors: Kai Li, Xuedong Wei, Guangbo Zhang, Miao Li, Xuefeng Zhang, Chenhao Zhou, Jianquan Hou and Hexing Yuan
    Citation: BMC Urology 2017 17:23
  6. In last years Metabolic Syndrome (MetS) has been closely associated to Benign Prostatic Enlargement (BPE) Aim of our study is to evaluate the effect of MetS and each single MetS parameter on prostate growth in...

    Authors: Mauro Gacci, Arcangelo Sebastianelli, Matteo Salvi, Cosimo De Nunzio, Linda Vignozzi, Giovanni Corona, Tommaso Jaeger, Tommaso Chini, Giorgio Ivan Russo, Mario Maggi, Giuseppe Morgia, Andrea Tubaro, Marco Carini and Sergio Serni
    Citation: BMC Urology 2017 17:22
  7. Authors: Hiroji Uemura, Nobuaki Matsubara, Go Kimura, Akito Yamaguchi, Dianne Athene Ledesma, Marco DiBonaventura, Ateesha F. Mohamed, Enrique Basurto, Ian McKinnon, Ed Wang, Kristen Concialdi, Aya Narimatsu and Yasuko Aitoku
    Citation: BMC Urology 2017 17:20

    The original article was published in BMC Urology 2016 16:63

  8. BAP1 and PBRM1 are frequently mutated in primary clear cell renal cell carcinoma (ccRCC) tumors; however, the frequency and clinical relevance of these mutations in metastatic ccRCC tumors is unknown. Addition...

    Authors: Jeanette E. Eckel-Passow, Daniel J. Serie, John C. Cheville, Thai H. Ho, Payal Kapur, James Brugarolas, R. Houston Thompson, Bradley C. Leibovich, Eugene D. Kwon, Richard W. Joseph and Alexander S. Parker
    Citation: BMC Urology 2017 17:19
  9. Prostate cancer is the most common malignancy among men in the US. Though considerable improvement in the diagnosis of prostate cancer has been achieved in the past decade, predicting disease outcome remains a...

    Authors: Hung N. Luu, Hui-Yi Lin, Karina Dalsgaard Sørensen, Olorunseun O. Ogunwobi, Nagi Kumar, Ganna Chornokur, Catherine Phelan, Dominique Jones, LaCreis Kidd, Jyotsna Batra, Kosj Yamoah, Anders Berglund, Robert J. Rounbehler, Mihi Yang, Sang Haak Lee, Nahyeon Kang…
    Citation: BMC Urology 2017 17:18
  10. We evaluate the efficacy and safety of metallic ureteric stenting using the Cook Resonance® stent in the treatment of chronic ureteric obstruction of benign and malignant aetiology. Published experience of usi...

    Authors: C. Patel, D. Loughran, R. Jones, M. Abdulmajed and I. Shergill
    Citation: BMC Urology 2017 17:16
  11. The treatment of bilateral complex renal stones is a tough challenge for urologists. This study aimed to evaluate the efficiency and safety of bilateral ultrasonography-guided multi-tract percutaneous nephroli...

    Authors: Taisheng Liang, Chenming Zhao, Gang Wu, Botao Tang, Xiangdong Luo, Shangguang Lu, Yu Dong and Huan Yang
    Citation: BMC Urology 2017 17:15
  12. Radical nephrectomy for renal cell carcinoma (RCC) is a risk factor for the development of chronic kidney disease (CKD), and the possibility of postoperative deterioration of renal function must be considered ...

    Authors: Ken Fukushi, Shingo Hatakeyama, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Osamu Soma, Teppei Matsumoto, Itsuto Hamano, Takuma Narita, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Yuriko Terayama, Tomihisa Funyu and Chikara Ohyama
    Citation: BMC Urology 2017 17:13
  13. In this study we sought if, in their quest to handle hypoxia, prostate tumors express target hypoxia-associated molecules and their correlation with putative functional genetic polymorphisms.

    Authors: Avelino Fraga, Ricardo Ribeiro, André Coelho, José Ramon Vizcaíno, Helena Coutinho, José Manuel Lopes, Paulo Príncipe, Carlos Lobato, Carlos Lopes and Rui Medeiros
    Citation: BMC Urology 2017 17:12
  14. Understanding men’s experience of prostate biopsy is important as the procedure is common, invasive and carries potential risks. The psychological aspects of prostate biopsy have been somewhat neglected. The a...

    Authors: Catherine Coyle, Eileen Morgan, Frances J. Drummond, Linda Sharp and Anna Gavin
    Citation: BMC Urology 2017 17:11
  15. Partial nephrectomy for small renal masses (SRM) may be useful for preserving renal function, but is technically more difficult than radical nephrectomy. Cryoablation may be performed under local anesthesia. T...

    Authors: Fumiya Hongo, Yasuhiro Yamada, Takashi Ueda, Terukazu Nakmura, Yoshio Naya, Kazumi Kamoi, Koji Okihara, Yusuke Ichijo, Tsuneharu Miki, Kei Yamada and Osamu Ukimura
    Citation: BMC Urology 2017 17:10
  16. To compare the treatment outcomes between percutaneous nephrolithotomy (PCNL) and retrograde intrarenal surgery (RIRS) for the management of stones larger than 2 cm in patients with solitary kidney.

    Authors: Yunjin Bai, Xiaoming Wang, Yubo Yang, Ping Han and Jia Wang
    Citation: BMC Urology 2017 17:9
  17. The immune escape or tolerance of cancer cells is considered to be closely involved in cancer progression. Programmed death-1 (PD-1) is an inhibitory receptor expressed on activating T cells, and several types...

    Authors: Takanobu Motoshima, Yoshihiro Komohara, Chaoya Ma, Arni Kusuma Dewi, Hirotsugu Noguchi, Sohsuke Yamada, Toshiyuki Nakayama, Shohei Kitada, Yoshiaki Kawano, Wataru Takahashi, Masaaki Sugimoto, Motohiro Takeya, Naohiro Fujimoto, Yoshinao Oda and Masatoshi Eto
    Citation: BMC Urology 2017 17:8
  18. To explore the diagnostic benefit of an additional image fusion of the sagittal plane in addition to the standard axial image fusion, using a sensor-based MRI/US fusion platform.

    Authors: Karsten Günzel, Hannes Cash, John Buckendahl, Maximilian Königbauer, Patrick Asbach, Matthias Haas, Jörg Neymeyer, Stefan Hinz, Kurt Miller and Carsten Kempkensteffen
    Citation: BMC Urology 2017 17:7
  19. The goal was to assess the natural history and management of patients with pathologically proven bilateral (synchronous) RO after undergoing initial partial nephrectomy (PN).

    Authors: Andrew R. Leone, Laura C. Kidd, Gregory J. Diorio, Kamran Zargar-Shoshtari, Pranav Sharma, Wade J. Sexton and Philippe E. Spiess
    Citation: BMC Urology 2017 17:6
  20. To evaluate quality of life, functional and oncological outcome after infravesical desobstruction and HIFU treatment for localized prostate cancer.

    Authors: G. Hatiboglu, I. V. Popeneciu, M. Deppert, J. Nyarangi-Dix, B. Hadaschik, M. Hohenfellner, D. Teber and S. Pahernik
    Citation: BMC Urology 2017 17:5
  21. Intermittent catheterisation is the method of choice for the management of bladder dysfunctions. Different urinary catheters are available, but there is conflicting evidence on which type of catheter is best. ...

    Authors: Carla Rognoni and Rosanna Tarricone
    Citation: BMC Urology 2017 17:4
  22. Stone retropulsion represents a challenge for intracorporeal lithotripsy of ureteral calculi. The consequences are an increased duration and cost of surgery as well as decreased stone-free rates. The use of ad...

    Authors: Nici Markus Dreger, Friedrich Carl von Rundstedt, Stephan Roth, Alexander Sascha Brandt and Stephan Degener
    Citation: BMC Urology 2017 17:3
  23. This study was designed to evaluate the efficacy and safety of fulranumab, a fully human monoclonal antibody directed against nerve growth factor (NGF), for pain relief in patients with interstitial cystitis/b...

    Authors: Hao Wang, Lucille J. Russell, Kathleen M. Kelly, Steven Wang and John Thipphawong
    Citation: BMC Urology 2017 17:2
  24. Immunotherapy with high-dose interleukin-2 (HD-IL2) results in long-term survival in some metastatic renal cell carcinoma (mRCC) patients but has significant acute toxicities. Biomarkers predicting response to...

    Authors: James A. Kuzman, David D. Stenehjem, Joseph Merriman, Archana M. Agarwal, Shiven B. Patel, Andrew W. Hahn, Anitha Alex, Dan Albertson, David M. Gill and Neeraj Agarwal
    Citation: BMC Urology 2017 17:1
  25. Calculus pyonephrosis is difficult to manage. The aim of this study is to explore the value of a patented suctioning sheath assisted minimally invasive percutaneous nephrolithotomy (MPCNL) in the treatment of ...

    Authors: Jianrong Huang, Leming Song, Donghua Xie, Monong Li, Xiaolin Deng, Min Hu, Zuofeng Peng, Tairong Liu, Chuance Du, Lei Yao, Shengfeng Liu, Shulin Guo and Jiuqing Zhong
    Citation: BMC Urology 2016 16:71
  26. Ureteral stenting has been a fundamental part of various urological procedures. Selecting a ureteral stent of optimal length is important for decreasing the incidence of stent migration and complications. The ...

    Authors: Takashi Kawahara, Kentaro Sakamaki, Hiroki Ito, Shinnosuke Kuroda, Hideyuki Terao, Kazuhide Makiyama, Hiroji Uemura, Masahiro Yao, Hiroshi Miyamoto and Junichi Matsuzaki
    Citation: BMC Urology 2016 16:70
  27. Lower urinary tract symptoms are highly prevalent and a large proportion of these symptoms are known to be associated with a dysfunction of the afferent pathways. Diagnostic tools for an objective and reproduc...

    Authors: Stéphanie van der Lely, Martina Stefanovic, Melanie R. Schmidhalter, Marta Pittavino, Reinhard Furrer, Martina D. Liechti, Martin Schubert, Thomas M. Kessler and Ulrich Mehnert
    Citation: BMC Urology 2016 16:69
  28. To compare the complications of traditional transrectal (TR) prostate biopsy and image fusion guided transperineal (TP) prostate biopsy in our center.

    Authors: Haifeng Huang, Wei Wang, Tingsheng Lin, Qing Zhang, Xiaozhi Zhao, Huibo Lian and Hongqian Guo
    Citation: BMC Urology 2016 16:68
  29. Anxiety disorders (ADs) are common with a high rate of medical comorbidities. Although the association between ADs and the overall cancer risk remains controversial, patients with ADs were found to be more lik...

    Authors: Yung-Chan Chen, Li-Ting Kao, Herng-Ching Lin, Hsin-Chien Lee, Chung-Chien Huang and Shiu-Dong Chung
    Citation: BMC Urology 2016 16:67
  30. Controversy remains on the superiority of combination therapy over monotherapy on ureteral stent-related symptoms (SRSs). We tend to explore if there is a necessity of combination therapy.

    Authors: Qinyu Liu, Banghua Liao, Ruochen Zhang, Tao Jin, Liang Zhou, Deyi Luo, Jiaming Liu, Hong Li and Kunjie Wang
    Citation: BMC Urology 2016 16:66
  31. Circumcision is a common minor surgical procedure and it is performed to a varying extent across countries and religions. Despite being a minor surgical procedure, major complications may result from it. In Gh...

    Authors: Kwaku Addai Arhin Appiah, Christian Kofi Gyasi-Sarpong, Roland Azorliade, Ken Aboah, Dennis Odai Laryea, Kwaku Otu-Boateng, Kofi Baah-Nyamekye, Patrick Opoku Manu Maison, Douglas Arthur, Isaac Opoku Antwi, Benjamin Frimpong-Twumasi, Edwin Mwintiereh Yenli, Samuel Kodzo Togbe and George Amoah
    Citation: BMC Urology 2016 16:65
  32. Up to a fifth of patients diagnosed with prostate cancer (PC) will develop castration-resistant prostate cancer (CRPC), which has been associated with a poor prognosis. The aim of this study was to consider th...

    Authors: Hiroji Uemura, Nobuaki Matsubara, Go Kimura, Akito Yamaguchi, Dianne Athene Ledesma, Marco DiBonaventura, Ateesha F. Mohamed, Enrique Basurto, Ian McKinnon, Ed Wang, Kristen Concialdi, Aya Narimatsu and Yasuko Aitoku
    Citation: BMC Urology 2016 16:63

    The Erratum to this article has been published in BMC Urology 2017 17:20

  33. Copy number variation (CNV) is a potential contributing factor to many genetic diseases. Here we investigated the potential association of CNV with nonsyndromic cryptorchidism, the most common male congenital ...

    Authors: Yanping Wang, Jin Li, Thomas F. Kolon, Alicia Olivant Fisher, T. Ernesto Figueroa, Ahmad H. BaniHani, Jennifer A. Hagerty, Ricardo Gonzalez, Paul H. Noh, Rosetta M. Chiavacci, Kisha R. Harden, Debra J. Abrams, Deborah Stabley, Cecilia E. Kim, Katia Sol-Church, Hakon Hakonarson…
    Citation: BMC Urology 2016 16:62
  34. Lower Urinary Tract Symptoms (LUTS) in men are a common clinical problem in urology and have been historically strictly linked to benign prostatic hyperplasia (BPH), which may lead to bladder outlet obstructio...

    Authors: Simone Albisinni, Ibrahim Biaou, Quentin Marcelis, Fouad Aoun, Cosimo De Nunzio and Thierry Roumeguère
    Citation: BMC Urology 2016 16:58
  35. The aim was to evaluate cancer-specific survival (CSS) and overall survival (OS) in patients with prostate cancer (PCa) recurrence who underwent salvage extended pelvic lymph node dissection (ePLND), taking in...

    Authors: Daniar K. Osmonov, Alexey V. Aksenov, David Trick, Carsten M. Naumann, Moritz F. Hamann, Amr Abou Faddan and Klaus-Peter Jünemann
    Citation: BMC Urology 2016 16:56
  36. To assess the efficacy and safety of intradetrusor onabotulinumtoxinA (OnabotA) injection treatment in patients with neurogenic lower urinary tract dysfunction (NLUTD), especially for patients with Parkinson d...

    Authors: Stephanie C. Knüpfer, Susanne A. Schneider, Mareike M. Averhoff, Carsten M. Naumann, Günther Deuschl, Klaus-Peter Jünemann and Moritz F. Hamann
    Citation: BMC Urology 2016 16:55
  37. Men diagnosed with prostate cancer (PCa) in specific regional areas in Victoria, Australia have a poorer five-year survival rate compared to men living elsewhere in Victoria. This study aims to describe patter...

    Authors: Rasa Ruseckaite, Fanny Sampurno, Jeremy Millar, Mark Frydenberg and Sue Evans
    Citation: BMC Urology 2016 16:54
  38. Previous studies have suggested a greater benefit for various outcomes in men diagnosed with benign prostatic hyperplasia (BPH) who are treated with dutasteride than for men treated with finasteride. This stud...

    Authors: Josephina G. Kuiper, Irene D. Bezemer, Maurice T. Driessen, Averyan Vasylyev, Claus G. Roehrborn, Fernie J. A. Penning-van Beest and Ron M. C. Herings
    Citation: BMC Urology 2016 16:53
  39. Methylation of the tumor suppressor gene H-cadherin (CDH13) has been reported in many cancers. However, the clinical effect of the CDH13 methylation status of patients with bladder cancer remains to be clarified.

    Authors: Feng Chen, Tao Huang, Yu Ren, Junjun Wei, Zhongguan Lou, Xue Wang, Xiaoxiao Fan, Yirun Chen, Guobin Weng and Xuping Yao
    Citation: BMC Urology 2016 16:52

Affiliated with

  • BMC Urology works with with Cochrane Urology in providing our authors with expert advice on systematic reviews and meta-analyses

Annual Journal Metrics

  • 2022 Citation Impact
    2.0 - 2-year Impact Factor
    2.2 - 5-year Impact Factor
    1.177 - SNIP (Source Normalized Impact per Paper)
    0.616 - SJR (SCImago Journal Rank)

    2023 Speed
    39 days submission to first editorial decision for all manuscripts (Median)
    170 days submission to accept (Median)

    2023 Usage 
    1,270,864 downloads
    484 Altmetric mentions 

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal